Trial Outcomes & Findings for H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil (NCT NCT04203199)

NCT ID: NCT04203199

Last Updated: 2023-09-15

Results Overview

Based on pilot data, the investigators expect an interaction between treatment (DLPFC or MPFC TMS) and time (Before vs. After rTMS) on reported painfulness using a quantitative sensory testing technique which determines the sensation and pain thresholds of pressure. Painfulness ratings will be assessed and reported before and after rTMS.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

39 participants

Primary outcome timeframe

rTMS treatment visit, an average of 2 and a half hours

Results posted on

2023-09-15

Participant Flow

There were 8 screen failures. Only 31 randomized.

Participant milestones

Participant milestones
Measure
First H1 Coil, Then H7 Coil
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H1 coil at TMS visit 1, H7 coil at TMS visit 2 Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
First H7 Coil, Then H1 Coil
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H7 coil at TMS visit 1, H1 coil at TMS visit 2. Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
First Intervention Period
STARTED
15
16
First Intervention Period
COMPLETED
15
15
First Intervention Period
NOT COMPLETED
0
1
Second Intervention Period
STARTED
15
15
Second Intervention Period
COMPLETED
14
15
Second Intervention Period
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
First H1 Coil, Then H7 Coil
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H1 coil at TMS visit 1, H7 coil at TMS visit 2 Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
First H7 Coil, Then H1 Coil
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H7 coil at TMS visit 1, H1 coil at TMS visit 2. Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
First Intervention Period
Lost to Follow-up
0
1
Second Intervention Period
Medication change
1
0

Baseline Characteristics

H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
First H1 Coil, Then H7 Coil
n=15 Participants
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H1 coil at TMS visit 1, H7 coil at TMS visit 2 Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
First H7 Coil, Then H1 Coil
n=16 Participants
There will be 1 screening and 2 TMS visits. The procedures will be identical for each TMS visit, except for the type of TMS delivered (H1 or H7 coil). Each participant will be assigned to both coils, with TMS type. Participants assigned to this arm will receive the H7 coil at TMS visit 1, H1 coil at TMS visit 2. Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards. Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
Total
n=31 Participants
Total of all reporting groups
Age, Continuous
51.27 years
STANDARD_DEVIATION 15.0 • n=5 Participants
43.88 years
STANDARD_DEVIATION 15.4 • n=7 Participants
47.45 years
STANDARD_DEVIATION 15.2 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
11 Participants
n=7 Participants
23 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
13 Participants
n=5 Participants
14 Participants
n=7 Participants
27 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
15 participants
n=5 Participants
16 participants
n=7 Participants
31 participants
n=5 Participants

PRIMARY outcome

Timeframe: rTMS treatment visit, an average of 2 and a half hours

Based on pilot data, the investigators expect an interaction between treatment (DLPFC or MPFC TMS) and time (Before vs. After rTMS) on reported painfulness using a quantitative sensory testing technique which determines the sensation and pain thresholds of pressure. Painfulness ratings will be assessed and reported before and after rTMS.

Outcome measures

Outcome measures
Measure
Real rTMS to the mPFC Using H7 Coil
n=29 Participants
One session of low frequency repetitive transcranial magnetic stimulation (rTMS) will be delivered to the left medial prefrontal cortex (mPFC) using the H7-coil (20 min total, 1200 pulses delivered at 1 Hz continuously, 1 train, 120% resting motor threshold (rMT)). Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards.
Real rTMS to the dlPFC Using H1 Coil
n=29 Participants
One session of high frequency repetitive transcranial magnetic stimulation (rTMS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC) using the H1-coil (20 min total, 3000 pulses delivered at 10 Hz, 60 trains, 50 pulses/train, 5 sec on/15 sec off, 120% resting motor threshold (rMT)). Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
Changes in Painfulness Thresholds Using the Quantitative Pain Testing (QST) Task, Which Utilizes Pressure From the Medoc Algomed Device (Measured in kiloPascals).
1.1 kPascals
Standard Deviation 101.3
-23.4 kPascals
Standard Deviation 89

SECONDARY outcome

Timeframe: rTMS treatment visit, an average of 2 and a half hours

The investigators do not expect an interaction between treatment (DLPFC or MPFC TMS) and time (Before vs. After rTMS) on pain tolerance thresholds using a quantitative sensory testing technique which determines the sensation and pain thresholds of pressure. Pain tolerance ratings will be assessed and reported before and after rTMS.

Outcome measures

Outcome measures
Measure
Real rTMS to the mPFC Using H7 Coil
n=29 Participants
One session of low frequency repetitive transcranial magnetic stimulation (rTMS) will be delivered to the left medial prefrontal cortex (mPFC) using the H7-coil (20 min total, 1200 pulses delivered at 1 Hz continuously, 1 train, 120% resting motor threshold (rMT)). Real rTMS to the mPFC using H7 Coil: This will be delivered with the Brainsway H7 coil system; 1200 pulses with the H7 coil helmet. Blinded using active/sham operator cards.
Real rTMS to the dlPFC Using H1 Coil
n=29 Participants
One session of high frequency repetitive transcranial magnetic stimulation (rTMS) will be delivered to the left dorsolateral prefrontal cortex (dlPFC) using the H1-coil (20 min total, 3000 pulses delivered at 10 Hz, 60 trains, 50 pulses/train, 5 sec on/15 sec off, 120% resting motor threshold (rMT)). Real rTMS to the dlPFC using H1 Coil: This will be delivered with the Brainsway H1 coil system; 3000 pulses with the H1 coil helmet. Blinded using active/sham operator cards.
Changes in Pain Tolerance Thresholds Using the Quantitative Pain Testing (QST) Task, Which Utilizes Pressure From the Medoc Algomed Device (Measured in kiloPascals).
4.8 kPascals
Standard Deviation 117.9
24.2 kPascals
Standard Deviation 134.4

Adverse Events

Real rTMS to the mPFC Using H7 Coil

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Real rTMS to the dlPFC Using H1 Coil

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Colleen Hanlon, PhD

Wake Forest University Health Sciences

Phone: 844-386-7001

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place